Ozempic face
What the FDA labels record as adverse events, each one tied back to the evidence it came from.
What is Ozempic face?
The popular name for facial volume loss during rapid weight loss on a GLP-1.
A 2025 Otolaryngology imaging cohort (PMID 40407186) put it at a median 9% midfacial volume loss, around 7% per 10 kg lost. It is fat leaving the face, not a drug toxicity, and slower titration and a slower loss curve reduce it.
GLP Watchdog writes these definitions from FDA labels and peer-reviewed PubMed literature.
Where Ozempic face comes up on this site
On GLP Watchdog, Ozempic face comes up in 1 research article.
Research that discusses it
Connected terms
Other terms under Side effects
Where the evidence lives
- The full GLP-1 glossary (150 terms, 8 categories)
- Research articles — written from primary sources
- Tools and calculators
- Compare GLP-1 telehealth providers